Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Pfizer expands plant in North Carolina

by Michael McCoy
August 20, 2017 | A version of this story appeared in Volume 95, Issue 33

Pfizer will spend $100 million to expand its gene therapy manufacturing facility in Sanford, N.C. Pfizer acquired the plant last year as part of its purchase of Bamboo Therapeutics, a gene therapy developer founded by three University of North Carolina, Chapel Hill, scientists. The facility uses adeno-associated ­viruses to deliver genes that teach cells how to make missing or defective proteins. Only one gene therapy, the rare-disease treatment Glybera, has been approved in the U.S. or Europe.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.